Source:http://linkedlifedata.com/resource/pubmed/id/21407935
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-3-16
|
pubmed:abstractText |
3, 4 Methylenedioxymethamphetamine (MDMA) also known as Ecstasy is a common recreational drug of abuse and reports of abuse of tricyclic antidepressants are also known. We report two cases of misuse of selective serotonin re-uptake inhibitors (SSRIs) antidepressants in combination with Ecstasy and their beneficial subjective effects experienced by misusers. We hypothesise the probable underlying pharmacological reasons and recommend its use in the treatment of neurotoxic effects of MDMA.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0019-5545
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195-7
|
pubmed:year |
2000
|
pubmed:articleTitle |
Rave drug (ecstasy) and selective serotonin reuptake inhibitor anti-depressants.
|
pubmed:affiliation |
A.N. SINGH, Consultant Psychiatrist, South Lincolnshire Healthcare NHS Trust, Beaconfield Centre, Beacon Lane, Grantham Lines, NG319DF, UK.
|
pubmed:publicationType |
Journal Article
|